Abstract
Background: The University of Kentucky Markey Cancer Center developed the data gathering and visualization platform Cancer InFocus (CIF) as a solution for cancer center catchment area surveillance. CIF was released in June 2022 and made available for use to other institutions through a no-cost licensing agreement. The purpose of this study was to evaluate the impact CIF has had on cancer centers since its release. Methods: The authors adapted an existing management evaluation framework to assess the impact of CIF across three spheres—idea dissemination, product engagement, and adopter satisfaction. This assessment included an online survey administered between the dates of September 18, 2023 and June 22, 2024 among 28 individuals at 13 CIF adopting institutions. Results: As of October 2024, the ideas and approaches of CIF had been disseminated with national audiences 13 times and featured in one peer-reviewed publication. Thirty-five institutions, including 26 National Cancer Institute–Designated Cancer Centers, had engaged in licensing CIF. In a user satisfaction survey among adopting institutions, a majority of individuals indicated they were gathering more data (91.7%) and requiring less effort to disseminate data (72.0%) using CIF than under their previous methods. Conclusions: CIF has demonstrated a broad and positive impact on cancer center catchment area surveillance in the 2 years since its release. CIF represents a high value, low-cost option for cancer centers wanting to build a cancer surveillance dashboard. The framework used for evaluating CIF's impact can be adapted to assess the impact of other open-source software built and distributed by cancer centers.
Original language | English |
---|---|
Article number | e35710 |
Journal | Cancer |
Volume | 131 |
Issue number | 2 |
DOIs | |
State | Published - Jan 15 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
Funding
Pamela C. Hull reports consulting fees from AdventHealth, Indiana University, Kentucky Rural Health Association, Moffitt Cancer Center, Ohio State University, St. Jude Children's Research Hospital, and the University of Arizona Cancer Center; fees for professional activities from St. Jude Children's Research Hospital; and grant/contract funding from American Cancer Society, Centers for Disease Control and Prevention, Eli Lilly and Company, Kentucky Cabinet for Health and Family Services, Merck Company Foundation, the National Cancer Institute, and the US Department of Agriculture. The other authors declare no conflicts of interest. This research was supported by the Cancer Research Informatics Shared Resource Facility of the University of Kentucky Markey Cancer Center, through a grant from the National Cancer Institute of the National Institutes of Health (P30CA177558). Pamela C. Hull and Caree R. McAfee received support from grant P30CA177558. Pamela C. Hull also received support from the William Stamps Farish Endowed Chair in Cancer Research. The University of Kentucky institutional review board approved the research procedures under protocol 87941.
Funders | Funder number |
---|---|
Merck Company Foundation | |
Centers for Disease Control and Prevention | |
University of Kentucky Markey Cancer Center | |
Moffitt Cancer Center’s Cancer Center | |
University of Southern Indiana | |
Kentucky Cabinet for Health and Family Services | |
Eli Lilly and Company | |
Kentucky Rural Health Association | |
National Childhood Cancer Registry – National Cancer Institute | |
University of Arizona Cancer Center | |
American Cancer Society-Michigan Cancer Research Fund | |
St. Jude Children's Research Hospital | |
Ohio State University, St. Jude Children's Research Hospital | |
U.S. Department of Agriculture | |
National Institutes of Health (NIH) | P30CA177558 |
University of Kentucky | 87941 |
Keywords
- cancer surveillance
- catchment area
- evaluation
- software
ASJC Scopus subject areas
- Oncology
- Cancer Research